Genmab — Marts 2023

[E_L]

Amivantamab efficacy in pretreated NSCLC with EGFR Exon 20 insertion mutations persists long term https://dailyreporter.esmo.org/european-lung-cancer-congress-2023/elcc-2023/amivantamab-efficacy-in-pretreated-nsclc-with-egfr-exon-20-insertion-mutations-persists-long-term

[Solsen]

Rigtig spændende med combi med venetoclax, som er et fantastisk stof. Det kan der komme noget stort ud af for Genmab/Abbvie og patienterne.

[StockBull]

Det er i vores mørkeste øjeblikke, at vi skal fokusere for at se lyset.

[E_L]

Venetoclax is also from AbbVie if i am not mistaken...

[Solsen]

Correct

[Sukkeralf]

In partnership with Roche/Genentech though

[E_L]

https://twitter.com/tnewsomdavis/status/1641480986746662913 "Very surprised that 1/3 of audience opted
for 1L Amivantamab"

[E_L]

Daratumumab, an anti-CD38 effective in two cases of severe refractory myositis https://www.institut-myologie.org/en/2023/03/30/daratumumab-an-anti-cd38-effective-in-two-cases-of-severe-refractory-myositis/

[StockBull]

Morn, Fibonacci købssignal https://www.proinvestor.com/boards/111776/

[E_L]

https://onkologisktidsskrift.dk/behandlinger/lungekraeft/2835-nye-data-for-rybrevant-bekraefter-stoffets-potentiale-mod-egfr-exon-20-muteret-nsclc.html Nye data for Rybrevant bekræfter stoffets potentiale mod EGFR exon 20-muteret NSCLC

[E_L]

AMGEN on Horizon acquisition: We believe that our decades of leadership in inflammation and nephrology, combined with our global presence and world-class biologic capabilities, will enable us to reach many more patients with life-changing medicines like TAVNEOS and TEPEZZA than either company could achieve on its own. https://www.amgen.com/stories/2023/03/2022-letter-to-shareholders

[troldmanden]

Nå mon vi skal have et positivt udfald af voldgift før 3000 kan brydes og agere ny bund. NPV impact er signifikant større på udfaldet af den afgørelse end af epco. Så bliver rart at komme på den anden side af retssagen. At få reduceret usikkerheden der tynger

[E_L]

end of month & quarter. 4th red month in a row.

• • • 28/2 18:07
      af E L
      3rd red month in a row. Since the lows of 2011 we only once had 4 negative months in a row, at the end of 2017